| Labcorp

Lucas Rifkin, MD, FCAP

Dr. Lucas Rifkin is a board-certified hematopathologist as well as anatomic and clinical pathologist in the medical affairs department. He has been with Labcorp Drug Development since August 2019. In his current role, Lucas is a senior medical director with management and leadership responsibilities; he serves as the CAP/CLIA laboratory director for the Indianapolis central laboratory location. Additionally, Lucas reviews cases in anatomic pathology, flow cytometry and hematopathology.

Sriram Ramanan, PhD

Dr. Sriram Ramanan brings more than 12 years of combined preclinical and clinical contract research organization experience across broad therapeutic areas including oncology, immunology and cell/gene therapy. He joined Labcorp Drug Development in 2014.

Maria Prendes

Dr. Maria Prendes provides scientific oversight in clinical and preclinical programs as the head of oncology for the Biomarker Solution Center. Maria has over 25 years of experience identifying and characterizing biomarkers and holds 48 patents on methods to characterize biomarkers in oncology. In her role, she has participated in more than 2,000 clinical programs in oncology providing scientific biomarker support. As a subject matter expert, Maria has participated in numerous international conferences as a podium speaker, moderator and session chairwoman.

Pingping (Peter) He

Peter He Pingping joined Labcorp Central Laboratory Services in 2021 and is currently a staff scientist in the anatomic pathology and histology department. Peter supports lab operations to ensure smooth transitions of assays into production for histology. He also participates in developing and identifying new strategies, techniques and instrumentation for immunohistochemistry innovation in global central laboratory operations. Peter specializes in immunohistochemistry (singleplex and multiplex).

Pritty Patel

Pritty Patel provides global leadership and direction in developing Labcorp Central Laboratory Services’ capabilities in clinical microbiology for anti-infective studies while also leading the continuous development of the science, strategy and breadth of departmental capabilities. She continues to develop and implement scientific and business strategy for Labcorp Central Labs’ global clinical microbiology laboratories for Phase II and III clinical trials. Additionally, Pritty is responsible for implementing quality action plans.

Satya N. Narla, PhD, NRCC(CC)

Dr. Satya Narla is an associate director for the safety testing team at Labcorp Drug Development’s central laboratory. She joined Labcorp in January 2016 as a senior scientist in the immunology department and was promoted to associate director of operations for the safety testing department in 2019.

Sonia Meynier, PhD

Dr. Sonia Meynier joined Labcorp Drug Development in 2021 as a staff scientist in the targeted cell isolation department. In her role, Sonia is responsible for improving and bringing new techniques for cell isolation, defining and analyzing the validations for new procedures, reviewing and providing pricing for new studies and collaborating with the lab to highlight improvements that increase product quality.

Paul Mésange, PhD

Dr. Paul Mésange is the principal scientist of the histology department at Labcorp Central Laboratory Services. Paul completed his PhD in pharmacology in 2014 at Paris Descartes University (France). After two postdoctorates working on preclinical trials at Stanford University (California), he joined a contract research organization in Amsterdam, the Netherlands. Paul joined Labcorp Central Labs in July 2018.

Robert Martone

Robert Martone is a research scientist with deep expertise in neurodegeneration, neuro-oncology, biomarkers and drug discovery. He investigated hereditary neuropathies and the molecular biology of the blood-brain barrier at Columbia University and subsequently managed a portfolio of drug discovery programs at Wyeth Neuroscience targeting Alzheimer’s and Parkinson’s diseases. He was the neuroscience therapeutic area lead for the Labcorp Biomarker Center of Excellence and later established a protein biomarker laboratory at St. Jude Children’s Research Hospital.

LiBin Ma, MD, PhD

Dr. LiBin Ma is a senior medical director in Labcorp’s global medical affairs division. In his current role, LiBin provides medical consultation for Labcorp Central Laboratory Services as well as leadership for global medical affairs division. Prior to this, he was senior director of medical affairs and science for the Asia-Pacific region, responsible for the strategic and operational activities for medical affairs in the region.

Managing Your Health

Diseases & Specialties

Treatment Methods & Product Testing

Lab Disciplines & Services